International Biotechnology (LON:IBT) Shares Pass Below 200-Day Moving Average - Time to Sell?

International Biotechnology (LON:IBT - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 680.90 ($8.57) and traded as low as GBX 674 ($8.48). International Biotechnology shares last traded at GBX 680 ($8.56), with a volume of 39,054 shares changing hands.

International Biotechnology Trading Down 0.6 %

The stock has a market cap of £251.33 million, a PE ratio of 1,416.67 and a beta of 0.21. The firm has a 50-day moving average price of GBX 694.15 and a 200-day moving average price of GBX 680.90. The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46.

International Biotechnology Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, January 24th. Stockholders of record on Thursday, December 19th will be paid a GBX 15.56 ($0.20) dividend. This represents a dividend yield of 2.21%. The ex-dividend date is Thursday, December 19th. This is an increase from International Biotechnology's previous dividend of $14.50. International Biotechnology's dividend payout ratio is currently 6,041.67%.

Insider Activity

In other International Biotechnology news, insider Katherine Cornish-Bowden acquired 1,500 shares of International Biotechnology stock in a transaction that occurred on Tuesday, December 17th. The stock was bought at an average cost of GBX 713 ($8.97) per share, for a total transaction of £10,695 ($13,457.91). Corporate insiders own 4.18% of the company's stock.

About International Biotechnology

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.